During the last session, SI-BONE Inc. (NASDAQ:SIBN)’s traded shares were 0.53 million, with the beta value of the company hitting 1.40. At the end of the trading day, the stock’s price was $12.50, reflecting an intraday gain of 3.73% or $0.45. The 52-week high for the SIBN share is $34.38, that puts it down -175.04 from that peak though still a striking 4.64% gain since the share price plummeted to a 52-week low of $11.92. The company’s market capitalization is $466.25M, and the average trade volume was 277.13K shares over the past three months.
SI-BONE Inc. (SIBN) received a consensus recommendation of a Buy from analysts. That translates to a mean rating of 1.70. SIBN has a Sell rating from 0 analyst(s) out of 7 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 7 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.46.
SI-BONE Inc. (NASDAQ:SIBN) trade information
SI-BONE Inc. (SIBN) registered a 3.73% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 3.73% in intraday trading to $12.50 this Friday, 05/13/22, hitting a weekly high. The stock’s 5-day price performance is -27.62%, and it has moved by -42.74% in 30 days. Based on these gigs, the overall price performance for the year is -60.89%.
The consensus price target of analysts on Wall Street is $27.71, which implies an increase of 54.89% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $20.00 and $36.00 respectively. As a result, SIBN is trading at a discount of -188.0% off the target high and -60.0% off the low.
SI-BONE Inc. (SIBN) estimates and forecasts
Statistics show that SI-BONE Inc. has underperformed its competitors in share price, compared to the industry in which it operates. SI-BONE Inc. (SIBN) shares have gone down -43.97% during the last six months, with a year-to-date growth rate less than the industry average at -7.60% against 4.10. Yet analysts are ramping up their growth forecast for the fiscal year 2022. Revenue is predicted to shrink -9.50% this quarter and then jump 12.50% in the quarter after that. In the rating firms’ projections, revenue will increase 19.00% compared to the previous financial year.
Revenue for the current quarter is expected to be $25.31 million as predicted by 6 analyst(s). Meanwhile, a consensus of 6 analyst(s) estimates revenue growth to $27.56 million by the end of Sep 2022. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $21.96 million and $22.49 million respectively. In this case, analysts expect current quarter sales to grow by 15.30% and then jump by 22.50% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -12.60%. While earnings are projected to return -13.50% in 2022, the next five years will return 8.90% per annum.
SI-BONE Inc. is due to release its next quarterly earnings between August 01 and August 05. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
SI-BONE Inc. (NASDAQ:SIBN)’s Major holders
SI-BONE Inc. insiders own 1.69% of total outstanding shares while institutional holders control 106.88%, with the float percentage being 108.72%. Brown Advisory Inc. is the largest shareholder of the company, while 189 institutions own stock in it. As of Mar 30, 2022, the company held over 3.17 million shares (or 9.36% of all shares), a total value of $71.71 million in shares.
The next largest institutional holding, with 2.71 million shares, is of Blackrock Inc.’s that is approximately 8.00% of outstanding shares. At the market price on Mar 30, 2022, these shares were valued at $61.23 million.
Also, the Mutual Funds coming in first place with the largest holdings of SI-BONE Inc. (SIBN) shares are Brown Advisory Fds–Brown Advisory Small Cap Growth Fd and Advisors Inner Circle Fund II-Champlain Small Company Fund. Data provided on Feb 27, 2022 indicates that Brown Advisory Fds–Brown Advisory Small Cap Growth Fd owns about 0.98 million shares. This amounts to just over 2.90 percent of the company’s overall shares, with a $21.71 million market value. The same data shows that the other fund manager holds slightly less at 0.94 million, or about 2.76% of the stock, which is worth about $20.77 million.